Esprinet S.p.A. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was EUR 1,139.44 million compared to EUR 1,166.04 million a year ago. Net income was EUR 10.07 million compared to EUR 10.23 million a year ago. Basic earnings per share from continuing operations was EUR 0.2 compared to EUR 0.21 a year ago. Diluted earnings per share from continuing operations was EUR 0.2 compared to EUR 0.2 a year ago.